【摘要】 67例脑动脉硬化症、偏头痛及口服避孕药者,以双盲方法投药,口服ASA 50 mg/日7天后,血小板聚集功能分别由ADP和Adr诱导而受到显著抑制,抑制率分别为56.6%和57.27%;14例偏头痛患者,以相同方法投药,口服SF 300 mg/日,2l～28天上述血小板功能的抑制率分别为54.1%和36.1%。ASA与SF比较,SF的抑制作用较为和缓,有可能成为预防血栓形成的新药。更多还原

【Abstract】 Sixty seven cerebroarteriosclerosis and migraine patients were treated with ASA(50mg/day) for 7 days, the platelet aggregation induced by ADP and Adr were measured separately. 14 migraine patients were treated with SF (300mg/day) for 21-28 days. Platelet aggregations were inhibited by 56.6% (ADP) and 57.27% (Adr) through ASA treatment, and by 54.1% (ADP) and 36.1% (Adr) by SF treatment. SF showed significant antiplatelet aggregation effects. The result indicates that SF may be effective in preventing thrombosis.更多还原